Skip to content
Tata Chemicals logo

Tata Chemicals

TATACHEM NSE
₹639.30 −10.75 (−1.65%)
Market Cap
₹16,287 Cr
P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 20 Nov 2026 ₹639.30 1Y −164.80 −20.5%
Start ₹804.10

Key Fundamentals

SmallcapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
3.42%
Debt to Equity
0.35
EPS (TTM)
−₹92.78
Book Value
₹860.55
Market Cap
₹16,287 Cr
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
0.74
ROE
1.27%
Dividend Yield
1.69%
EBITDA
₹2,121 Cr
52W High
₹854.85
52W Low
₹570.05
Day Range
₹636.95 – ₹678.60
Volume
39,23,477

Peer Comparison

Commodities › Chemicals & Petrochemicals › Commodity Chemicals

Tata Chemicals peer comparison
2,514.8032.6674,5454.870.20%14.30%14.60%18,2652,283
1,437.2015.5818,1432.390.68%11.10%11.40%12,4321,164
Tata Chemicals (this company)
639.30—16,2870.741.73%1.27%3.42%15,420−2,175
3,375.55100.587,3039.910.13%20.30%23.90%78470
465.256.506,8360.734.49%9.14%12.00%9,2151,052
593.0032.854,3550.823.06%−0.05%1.42%4,772133
445.158.864,1011.152.64%13.00%17.40%3,138473
Median 7 companies639.3024.127,3031.151.73%11.10%12.00%9,215473

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

34 Poor

Data confidence 91/100

Category scores

Quality
21
Poor
Returns, margins, earnings quality 22% weight
Valuation
76
Strong
Cheap vs sector & own history 24% weight
Growth
27
Poor
Sales & profit trajectory 9% weight
Financial Health
27
Poor
Solvency, leverage, coverage 9% weight
Momentum
32
Poor
Trend strength, vol-adjusted 12% weight
Ownership
20
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Stock is trading at 0.74 times its book value
  • Company has been maintaining a healthy dividend payout of 82.4%

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.41% over past five years.
  • Company has a low return on equity of 1.59% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish478
OscillatorsBullish072
Moving AveragesStrong Bullish406

Key readings

RSI (14)
56.76
Neutral
MACD (12,26,9)
4.51
Bullish
SMA (50)
628.61
Bullish
SMA (200)
681.53
Bearish

As of

Analyst Rating

Based on 7 analysts
SELL57%

1 of 7 analysts rate Buy, 2 Hold, 4 Sell.

As of

BUY
1
14%
HOLD
2
29%
SELL
4
57%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y−0.20%
5Y+7.41%
3Y−4.58%
1Y−2.04%
TTM+4.93%

Net profit

Net profit growth by window
10YTurned to loss
5YTurned to loss
3YTurned to loss
1YTurned to loss
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
10Y−5.90%
5Y−9.03%
3Y−24.69%
1Y−27.94%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−1.71 pp
5Y−2.38 pp
3Y−10.37 pp
1Y−0.74 pp
TTM−3.28 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹10,346 Cr
Mar 2018₹10,270 Cr
Mar 2019₹10,337 Cr
Mar 2020₹10,357 Cr
Mar 2021₹10,200 Cr
Mar 2022₹12,622 Cr
Mar 2023₹16,789 Cr
Mar 2024₹15,421 Cr
Mar 2025₹14,887 Cr
Mar 2026₹14,584 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1,234 Cr
Mar 2018₹2,702 Cr
Mar 2019₹1,387 Cr
Mar 2020₹7,228 Cr
Mar 2021₹436 Cr
Mar 2022₹1,405 Cr
Mar 2023₹2,434 Cr
Mar 2024₹435 Cr
Mar 2025₹387 Cr
Mar 2026−₹1,715 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹1,840 Cr −13.3% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk high

Tata Chemicals Ltd trades at ₹649.45 as of 2026-11-17 with a market cap of ₹16,545 crore and a price-to-book ratio of 0.75, indicating a significant discount to book value. However, the company reports a negative TTM EPS of -₹92.78, a negative ROE of -7.73%, and a negative ROCE of -2.69%, reflecting deep profitability challenges. The stock sits 24% below its 52-week high of ₹854.85 while compounded profit growth over the trailing twelve months stands at -288%.

Bull Case 7
  • Stock trades at a price-to-book ratio of just 0.75 as of 2026-11-17, well below book value, suggesting potential deep-value opportunity for contrarian investors
  • The company has maintained a healthy dividend payout ratio of 82.4%, and the current dividend yield stands at 1.8%, providing some income cushion
  • Debt-to-equity ratio is a manageable 0.36, indicating the balance sheet is not over-leveraged despite the current earnings downturn
  • Compounded sales growth over 10 years is flat at 0% but the TTM revenue growth has turned positive at 5%, suggesting a possible early-stage revenue recovery
  • The 5-year compounded sales growth of 7% shows the company has been able to grow its top line over medium-term cycles even if profitability lagged
  • 10-year stock CAGR of 12% indicates the company has historically generated meaningful long-term shareholder returns despite recent weakness
  • The stock is 24% below its 52-week high of ₹854.85 and only 14% above its 52-week low of ₹570.05, with much of the negative news potentially already priced in
Bear Case 8
  • TTM EPS is deeply negative at -₹92.78, rendering the P/E ratio meaningless and signalling severe bottom-line deterioration
  • ROE stands at -7.73% and ROCE at -2.69% as of the latest period, meaning the company is destroying shareholder value rather than generating returns
  • Compounded profit growth over the TTM period is -288%, reflecting a dramatic swing into losses
  • 3-year compounded profit growth of -51% shows the earnings decline is not a one-off event but a sustained multi-year trend
  • 3-year ROE averages just 2% and last year's ROE was only 1%, indicating persistent inability to generate adequate returns on equity even before the latest deterioration
  • Interest coverage ratio is low, raising concerns about the company's ability to comfortably service its debt obligations during the current earnings downturn
  • 5-year compounded sales growth of roughly 7% is modest for a mid-cap company and the 3-year compounded sales growth is negative at -5%, indicating top-line contraction in the more recent period
  • Stock has delivered a 1-year return of -27% and a 3-year CAGR of -14%, significantly underperforming broader market indices over these periods

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

22h ago

TL;DR: Tata Chemicals faces a mixed period dominated by the unresolved Kenya operations dispute, where its subsidiary TCML saw meaningful profit declines in FY26. A favourable court jurisdiction ruling provides some relief, but the broader regulatory and operational uncertainty in Kenya — contributing roughly 6% of consolidated EBITDA — remains an overhang. Institutional selling by a major mutual fund adds to near-term caution, and the forward outlook hinges on the resolution of the Kenya committee review and the company's ability to stabilise subsidiary earnings.

Headwinds 3
  • Kenya subsidiary EBITDA decline Oct 24

    TCML's EBITDA fell to ₹101 crore in FY26 from ₹142 crore in FY25, and profit after tax dropped to ₹48 crore from ₹118 crore. Revenue also declined to ₹586 crore from ₹612 crore.

  • Kenya operations dispute ongoing Oct 24

    An ongoing dispute between TCML and Kenya's Ministry of Mining led to a reported directive to cease operations. A high-level committee formed after a Sep 8 meeting is conducting a technical review, with outcomes still pending.

  • Major MF cuts stake sharply Nov 6

    ICICI Prudential Mutual Fund sold 52.55 lakh shares via open market, reducing its holding to 2.94% from 5.01% — a significant institutional reduction.

Positives 1
  • Kenya court ruling favours Tata Oct 24

    Kenya's High Court ruled on Oct 23 that it lacks jurisdiction over the TCML dispute and cannot take further steps, removing one legal overhang for the subsidiary.

Neutral 2
  • Company denies IPO reports Nov 17

    Tata Chemicals responded to a BSE inquiry about IPO-related news, denying knowledge of any negotiations or undisclosed details.

  • Analyst meet on Nov 16 Nov 11

    Tata Chemicals confirmed participation in the JM Financial Annual India Conference on Nov 16 in Mumbai, with no unpublished price sensitive information to be shared.

Quarterly Results

₹ Cr
TATACHEM quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
3,998
3,730
3,475
3,789
3,999
3,590
3,509
3,719
3,877
3,550
3,438
4,255
4,177
Expenses
3,191
3,188
3,032
3,215
3,381
3,156
3,182
3,070
3,340
3,205
3,164
3,717
3,796
Operating Profit
807
542
443
574
618
434
327
649
537
345
274
538
381
OPM %
20%
15%
13%
15%
15%
12%
9%
17%
14%
10%
8%
13%
9%
Other Income
85
98
−861
116
152
−10
29
138
128
21
−1,760
56
115
Interest
145
132
130
133
145
148
137
147
144
146
153
148
151
Depreciation
234
246
271
273
277
280
293
280
285
293
343
336
351
Exceptional Items
102
—
—
—
—
—
—
—
—
—
—
—
—
PBT
615
262
−819
284
348
−4
−74
360
236
−73
−1,982
110
−6
Tax %
20%
26%
3%
33%
23%
425%
−34%
12%
35%
−5%
7%
45%
733%
Net Profit
495
194
−841
190
267
−21
−49
316
154
−69
−2,116
60
−50
EPS (₹)
16.80
6.20
−33.36
5.89
7.61
−2.08
−2.20
9.89
3.02
−3.65
−83.67
−0.67
−4.79
YoY Sales growth
−6
−10
−21
−10
0
−4
1
−2
−3
−1
−2
14
8

Profit & Loss

₹ Cr
TATACHEM profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
17,204
14,873
10,346
10,270
10,337
10,357
10,200
12,622
16,789
15,421
14,887
14,584
15,420
Expenses
15,305
12,777
8,249
6,926
8,538
8,411
8,693
10,303
12,969
12,574
12,934
12,779
13,882
Operating Profit
1,900
2,096
2,097
3,344
1,799
1,945
1,506
2,319
3,820
2,847
1,953
1,805
1,538
OPM %
11%
14%
20%
33%
17%
19%
15%
18%
23%
18%
13%
12%
10%
Other Income
183
210
293
262
785
6,480
254
472
218
−507
287
−1,473
−1,568
Interest
461
525
297
326
354
342
367
303
406
530
563
590
598
Depreciation
463
526
512
518
568
666
759
806
892
980
1,123
1,201
1,323
PBT
1,159
1,255
1,580
2,763
1,661
7,416
634
1,682
2,742
830
554
−1,459
−1,951
Tax %
30%
20%
22%
2%
17%
3%
31%
16%
11%
46%
30%
18%
—
Net Profit
802
1,006
1,234
2,702
1,387
7,228
436
1,405
2,434
435
387
−1,715
−2,175
EPS (₹)
23.41
30.24
38.98
95.49
45.37
274.97
10.06
49.36
90.93
10.52
9.22
−74.41
−92.78
Div. Payout %
53%
33%
28%
23%
28%
4%
99%
25%
19%
143%
119%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
Sales growth
8
−14
−30
−1
1
0
−2
24
33
−8
−3
−2
5

Balance Sheet

₹ Cr
TATACHEM balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
255
255
255
255
255
255
255
255
255
255
255
255
255
Reserves
5,297
6,600
7,653
10,847
12,086
12,643
14,035
17,998
19,466
21,986
21,339
20,951
21,668
Borrowings
8,379
9,090
7,072
6,108
6,130
7,702
6,933
7,025
6,296
5,563
7,072
8,001
7,762
Other Liabilities
6,872
8,402
8,607
8,648
8,398
7,073
7,115
8,566
8,923
8,907
9,084
9,791
9,640
Total Liabilities
20,802
24,346
23,587
25,858
26,869
27,673
28,337
33,843
34,940
36,711
37,750
38,998
39,325
Fixed Assets
11,359
13,431
12,644
12,787
13,551
15,356
15,261
16,044
17,092
17,861
19,600
20,602
20,798
CWIP
189
350
333
409
774
835
1,094
1,667
2,410
2,217
1,913
1,038
908
Investments
443
2,188
2,787
2,840
5,615
4,285
5,816
7,683
7,448
9,739
9,144
9,886
9,482
Other Assets
8,811
8,377
7,822
9,822
6,929
7,198
6,167
8,449
7,990
6,894
7,093
7,472
8,137
Total Assets
20,802
24,346
23,587
25,858
26,869
27,673
28,337
33,843
34,940
36,711
37,750
38,998
39,325

Cash Flow

₹ Cr
TATACHEM cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,274
2,332
3,531
1,870
1,581
1,780
2,037
1,644
2,971
3,016
1,761
1,269
Investing
−663
−463
−985
2,714
−1,927
−2,285
−1,147
−817
−1,149
−605
−1,667
−766
Financing
−1,087
−1,802
−2,341
−2,089
−1,712
−129
−1,456
−755
−2,076
−2,494
29
−670
Net Cash Flow
−477
68
205
2,494
−2,058
−634
−565
72
−254
−83
123
−167
Free Cash Flow
709
1,645
2,888
1,140
502
611
804
379
1,427
1,193
−191
129
CFO/EBITDA
86
129
190
71
115
99
142
82
88
120
102
67

Ratios

TATACHEM financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
73
88
74
46
51
56
50
56
57
45
47
52
Inventory Days
137
119
244
304
315
347
257
317
282
341
324
353
Days Payable
138
99
232
307
269
302
256
338
289
320
318
293
Cash Conversion Cycle
72
107
86
43
97
100
51
35
50
66
53
113
Working Capital Days
−4
31
−4
27
−2
−102
−28
−29
29
−22
−21
−17
ROCE %
11%
11%
10%
16%
9%
36%
4%
8%
12%
8%
4%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tata Chemicals insights

69 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 37.98%
  • Public 25.41%
  • DIIs 19.65%
  • FIIs 11.70%
  • Others 5.23%
  • Government 0.03%

No promoter shares pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Tata Chemicals

What does Tata Chemicals Ltd do?
Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products
Where is Tata Chemicals Ltd (TATACHEM) listed?
Tata Chemicals Ltd trades as TATACHEM on the NSE and under code 500770 on the BSE.
Which sector does Tata Chemicals Ltd belong to?
Tata Chemicals Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
What is the market capitalisation of Tata Chemicals Ltd?
Tata Chemicals Ltd has a market capitalisation of ₹16,287 Cr as of 20 Nov 2026, which places it in the Smallcap band.
What is the 52-week high and low of Tata Chemicals Ltd?
Over the last 52 weeks Tata Chemicals Ltd has traded between ₹570.05 and ₹854.85 as of 20 Nov 2026.
Does Tata Chemicals Ltd pay dividends?
Tata Chemicals Ltd has a dividend yield of 1.69%.
What is the Return on Equity (ROE) of Tata Chemicals Ltd?
Tata Chemicals Ltd reported a return on equity of 1.27%. Its debt-to-equity ratio is 0.35.

Company Information

Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products

CEO Mr. Ramakrishnan Mukundan B.E.(Elec), MBA
Employees 4,789
Listed 1 Apr 1999
Face Value ₹10
Shares Outstanding 25,47,56,278

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TATACHEM.md for Tata Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More